Swiss National Bank
CDNA icon

Swiss National Bank’s CareDx CDNA Stock Holding History

Swiss National Bank’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Sell
87,400
-12,300
-12% -$268K ﹤0.01% 1817
2026
Q1 		$1.73M Hold
99,700
– – ﹤0.01% 1926
2025
Q4 		$1.88M Sell
99,700
-2,800
-3% -$46.9K ﹤0.01% 1903
2025
Q3 		$1.49M Buy
102,500
+1,900
+2% +$27.1K ﹤0.01% 1990
2025
Q2 		$1.97M Buy
100,600
+2,000
+2% +$35.5K ﹤0.01% 1816
2025
Q1 		$1.75M Hold
98,600
– – ﹤0.01% 1846
2024
Q4 		$2.11M Buy
98,600
+1,800
+2% +$43.8K ﹤0.01% 1826
2024
Q3 		$3.02M Buy
+96,800
New +$2.41M ﹤0.01% 1626
2023
Q4 		– Sell
-118,200
Closed -$827K – 2555
2023
Q3 		$827K Buy
118,200
+2,700
+2% +$24.9K ﹤0.01% 2344
2023
Q2 		$982K Hold
115,500
– – ﹤0.01% 2304
2023
Q1 		$1.06M Sell
115,500
-13,600
-11% -$174K ﹤0.01% 2220
2022
Q4 		$1.47M Buy
129,100
+2,900
+2% +$43K ﹤0.01% 2087
2022
Q3 		$2.15M Buy
126,200
+1,400
+1% +$30K ﹤0.01% 1825
2022
Q2 		$2.68M Hold
124,800
– – ﹤0.01% 1713
2022
Q1 		$4.62M Buy
124,800
+9,000
+8% +$351K ﹤0.01% 1485
2021
Q4 		$5.27M Buy
115,800
+800
+0.7% +$41.8K ﹤0.01% 1431
2021
Q3 		$7.29M Buy
115,000
+800
+0.7% +$60.9K ﹤0.01% 1188
2021
Q2 		$10.5M Buy
114,200
+7,200
+7% +$572K 0.01% 1001
2021
Q1 		$7.29M Buy
107,000
+1,800
+2% +$140K ﹤0.01% 1211
2020
Q4 		$7.62M Buy
105,200
+10,900
+12% +$632K 0.01% 1092
2020
Q3 		$3.58M Buy
94,300
+4,300
+5% +$145K ﹤0.01% 1389
2020
Q2 		$3.19M Buy
90,000
+15,900
+21% +$452K ﹤0.01% 1422
2020
Q1 		$1.62M Buy
74,100
+1,100
+2% +$24.6K ﹤0.01% 1578
2019
Q4 		$1.57M Buy
73,000
+2,000
+3% +$45.9K ﹤0.01% 1862
2019
Q3 		$1.6M Buy
71,000
+1,600
+2% +$44.3K ﹤0.01% 1783
2019
Q2 		$2.5M Buy
69,400
+9,500
+16% +$304K ﹤0.01% 1560
2019
Q1 		$1.89M Buy
59,900
+8,500
+17% +$248K ﹤0.01% 1696
2018
Q4 		$1.29M Buy
+51,400
New +$1.32M ﹤0.01% 1836

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's CDNA Position: Q2 2026 in Review

Swiss National Bank reduced its CareDx (CDNA) stake by 12% in Q2 2026, selling an estimated $268K and leaving 87,400 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Swiss National Bank first reported a position in CDNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $10.5M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Swiss National Bank held 87,400 shares of CareDx worth $2.49M as of Q2 2026.
  • Swiss National Bank sold 12,300 CareDx shares in Q2 2026, an estimated $268K.
  • CareDx made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1817 holding.
  • Swiss National Bank first reported a position in CareDx in Q4 2018 and has held it in 28 quarters since.
  • Swiss National Bank's CareDx position peaked at $10.5M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.